Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Main right hepatic duct entering the cystic duct: a case report.

Abe T, Ito S, Kaneda Y, Suto R, Noshima S.

Surg Case Rep. 2019 Mar 25;5(1):46. doi: 10.1186/s40792-019-0604-y.

2.

Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a Methionine.

Kharenko OA, Patel RG, Brown SD, Calosing C, White A, Lakshminarasimhan D, Suto RK, Duffy BC, Kitchen DB, McLure KG, Hansen HC, van der Horst EH, Young PR.

J Med Chem. 2018 Sep 27;61(18):8202-8211. doi: 10.1021/acs.jmedchem.8b00666. Epub 2018 Sep 13.

PMID:
30165024
3.

Structure-Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch.

Vicens Q, Mondragón E, Reyes FE, Coish P, Aristoff P, Berman J, Kaur H, Kells KW, Wickens P, Wilson J, Gadwood RC, Schostarez HJ, Suto RK, Blount KF, Batey RT.

ACS Chem Biol. 2018 Oct 19;13(10):2908-2919. doi: 10.1021/acschembio.8b00533. Epub 2018 Sep 20.

PMID:
30107111
4.

Intranasal administration of recombinant progranulin inhibits bronchial smooth muscle hyperresponsiveness in mouse allergic asthma.

Chiba Y, Danno S, Suto R, Suto W, Yamane Y, Hanazaki M, Katayama H, Sakai H.

Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L215-L223. doi: 10.1152/ajplung.00575.2016. Epub 2017 Oct 5.

5.

Interleukin-17A directly acts on bronchial smooth muscle cells and augments the contractility.

Chiba Y, Tanoue G, Suto R, Suto W, Hanazaki M, Katayama H, Sakai H.

Pharmacol Rep. 2017 Jun;69(3):377-385. doi: 10.1016/j.pharep.2016.12.007. Epub 2016 Dec 11.

PMID:
28267638
6.

Resistant maltodextrin or fructooligosaccharides promotes GLP-1 production in male rats fed a high-fat and high-sucrose diet, and partially reduces energy intake and adiposity.

Hira T, Suto R, Kishimoto Y, Kanahori S, Hara H.

Eur J Nutr. 2018 Apr;57(3):965-979. doi: 10.1007/s00394-017-1381-7. Epub 2017 Feb 4.

PMID:
28161724
7.

Anammox biofilm in activated sludge swine wastewater treatment plants.

Suto R, Ishimoto C, Chikyu M, Aihara Y, Matsumoto T, Uenishi H, Yasuda T, Fukumoto Y, Waki M.

Chemosphere. 2017 Jan;167:300-307. doi: 10.1016/j.chemosphere.2016.09.121. Epub 2016 Oct 11.

PMID:
27728889
8.

RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

Kharenko OA, Gesner EM, Patel RG, Norek K, White A, Fontano E, Suto RK, Young PR, McLure KG, Hansen HC.

Biochem Biophys Res Commun. 2016 Aug 12;477(1):62-67. doi: 10.1016/j.bbrc.2016.06.021. Epub 2016 Jun 6.

PMID:
27282480
9.

In Situ SR-XPS Observation of Ni-Assisted Low-Temperature Formation of Epitaxial Graphene on 3C-SiC/Si.

Hasegawa M, Sugawara K, Suto R, Sambonsuge S, Teraoka Y, Yoshigoe A, Filimonov S, Fukidome H, Suemitsu M.

Nanoscale Res Lett. 2015 Dec;10(1):421. doi: 10.1186/s11671-015-1131-9. Epub 2015 Oct 26.

10.

Discovery of a new chemical series of BRD4(1) inhibitors using protein-ligand docking and structure-guided design.

Duffy BC, Liu S, Martin GS, Wang R, Hsia MM, Zhao H, Guo C, Ellis M, Quinn JF, Kharenko OA, Norek K, Gesner EM, Young PR, McLure KG, Wagner GS, Lakshminarasimhan D, White A, Suto RK, Hansen HC, Kitchen DB.

Bioorg Med Chem Lett. 2015 Jul 15;25(14):2818-23. doi: 10.1016/j.bmcl.2015.04.107. Epub 2015 May 11.

PMID:
26022843
11.

RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist.

McLure KG, Gesner EM, Tsujikawa L, Kharenko OA, Attwell S, Campeau E, Wasiak S, Stein A, White A, Fontano E, Suto RK, Wong NC, Wagner GS, Hansen HC, Young PR.

PLoS One. 2013 Dec 31;8(12):e83190. doi: 10.1371/journal.pone.0083190. eCollection 2013.

12.

Perioperative synbiotic therapy in elderly patients undergoing gastroenterological surgery: a prospective, randomized control trial.

Okazaki M, Matsukuma S, Suto R, Miyazaki K, Hidaka M, Matsuo M, Noshima S, Zempo N, Asahara T, Nomoto K.

Nutrition. 2013 Oct;29(10):1224-30. doi: 10.1016/j.nut.2013.03.015. Epub 2013 Jul 16.

PMID:
23867209
13.

Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity.

Song K, Krause C, Shi S, Patterson M, Suto R, Grgurevic L, Vukicevic S, van Dinther M, Falb D, Ten Dijke P, Alaoui-Ismaili MH.

J Biol Chem. 2010 Apr 16;285(16):12169-80. doi: 10.1074/jbc.M109.087197. Epub 2010 Jan 4.

14.

[A recurrent case of lipid-secreting carcinoma of the breast successfully treated with capecitabine].

Suto R, Miyamoto S, Kaneda Y, Zenpo N, Kurata S, Nakayasu K, Kamei T.

Gan To Kagaku Ryoho. 2008 Sep;35(9):1599-602. Japanese.

PMID:
18799920
15.

EGFR mutation in gefitinib-responsive small-cell lung cancer.

Okamoto I, Araki J, Suto R, Shimada M, Nakagawa K, Fukuoka M.

Ann Oncol. 2006 Jun;17(6):1028-9. Epub 2005 Dec 15. No abstract available.

PMID:
16357019
16.

Prognostic predictive value of endoscopic ultrasound findings for invasive ductal carcinomas of pancreatic head.

Nakata B, Nishino H, Ogawa Y, Yokomatsu H, Kawasaki F, Kosaka K, Wada T, Suto R, Montani A, Hirakawa K.

Pancreas. 2005 Apr;30(3):200-5.

PMID:
15782094
17.

Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer.

Araki J, Okamoto I, Suto R, Ichikawa Y, Sasaki J.

Lung Cancer. 2005 Apr;48(1):141-4. Epub 2004 Dec 9.

PMID:
15777982
18.

Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis.

Tominaga K, Higuchi K, Okazaki H, Suto R, Hamaguchi M, Tanigawa T, Sasaki E, Shiba M, Watanabe T, Fujiwara Y, Oshitani N, Matsumoto T, Arakawa T.

Oncology. 2004;66(5):358-64.

PMID:
15331922
19.

Correlation of MAP kinases with COX-2 induction differs between MKN45 and HT29 cells.

Tominaga K, Higuchi K, Sasaki E, Suto R, Watanabe T, Fujiwara Y, Oshitani N, Matsumoto T, Kim S, Iwao H, Arakawa T.

Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:143-50.

20.

[Two cases of non-curatively resected scirrhous gastric cancer that responded well to weekly paclitaxel therapy].

Suto R, Nakafuji Y, Mochizuki K, Oka K, Jinbo M, Chiba F, Moriuchi H, Ikeda Y, Nawata S, Zempo N, Kurata S, Nakayasu K, Esato K, Kamei T.

Gan To Kagaku Ryoho. 2003 Dec;30(13):2119-23. Japanese.

PMID:
14712775
21.

Dominant-negative mutant of c-Jun gene transfer: a novel therapeutic strategy for colorectal cancer.

Suto R, Tominaga K, Mizuguchi H, Sasaki E, Higuchi K, Kim S, Iwao H, Arakawa T.

Gene Ther. 2004 Jan;11(2):187-93.

PMID:
14712303
22.

[Gene therapy for colon cancer].

Tominaga K, Suto R, Sasaki E, Watanabe T, Fujiwara Y, Higuchi K, Arakawa T, Shokei K, Iwao H.

Nihon Rinsho. 2003 Sep;61 Suppl 7:490-4. Japanese. No abstract available.

PMID:
14574942
23.

Structure and dynamics of nucleosomal DNA.

Muthurajan UM, Park YJ, Edayathumangalam RS, Suto RK, Chakravarthy S, Dyer PN, Luger K.

Biopolymers. 2003 Apr;68(4):547-56.

PMID:
12666179
24.

Crystal structures of nucleosome core particles in complex with minor groove DNA-binding ligands.

Suto RK, Edayathumangalam RS, White CL, Melander C, Gottesfeld JM, Dervan PB, Luger K.

J Mol Biol. 2003 Feb 14;326(2):371-80.

PMID:
12559907
25.

Video-assisted neck surgery for thyroid and parathyroid diseases.

Maeda S, Shimizu K, Minami S, Hayashida N, Kuroki T, Furuichi A, Sugiyama N, Ishigaki K, Suto R, Furui J, Kanematsu T.

Biomed Pharmacother. 2002;56 Suppl 1:92s-95s.

PMID:
12487261
26.
27.

A second primary esophageal cancer developing 7 years after chemoradiotherapy for advanced esophageal cancer.

Suto R, Enjoji A, Okudaira S, Furui J, Matsuo T, Kanematsu T.

J Gastroenterol. 2001 Jul;36(7):495-9.

PMID:
11480795
28.

Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides.

Gottesfeld JM, Melander C, Suto RK, Raviol H, Luger K, Dervan PB.

J Mol Biol. 2001 Jun 8;309(3):615-29.

PMID:
11397084
30.

Crystal structure of a nucleosome core particle containing the variant histone H2A.Z.

Suto RK, Clarkson MJ, Tremethick DJ, Luger K.

Nat Struct Biol. 2000 Dec;7(12):1121-4.

PMID:
11101893
31.
32.

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma.

Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, Fukuda H, Nakano H, Abe S, Tateishi A, Kijima H, Yamazaki H, Tamaoki N, Ueyama Y, Nakamura M.

Eur J Cancer. 1999 Jul;35(7):1089-93.

PMID:
10533453
34.

Surgery for abdominal aortic aneurysms associated with malignancy.

Kurata S, Nawata K, Nawata S, Hongo H, Suto R, Nagashima H, Kuroda Y, Nakayasu K, Shirasawa B, Esato K.

Surg Today. 1998;28(9):895-9.

PMID:
9744397
35.
36.

Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.

Suto R, Abe Y, Nakamura M, Ohnishi Y, Yoshimura M, Lee YH, Imanishi T, Yamazaki H, Kijima H, Tokunaga T, Oshika Y, Hiraoka N, Tamaoki N, Fukuda H, Ueyama Y.

Int J Oncol. 1998 Feb;12(2):287-91.

PMID:
9458350
37.

Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity.

Blachere NE, Li Z, Chandawarkar RY, Suto R, Jaikaria NS, Basu S, Udono H, Srivastava PK.

J Exp Med. 1997 Oct 20;186(8):1315-22.

38.

A case of epithelioid hemangioendothelioma associated with an artery.

Akashi K, Yasuda M, Suto R, Fukuda H, Itoh J, Tsutsumi Y, Osamura RY.

Tokai J Exp Clin Med. 1997 May;22(2):65-9.

PMID:
9608633
39.

A case of malignant schwannoma with overexpression of multidrug resistance gene (MDR1) after chemotherapy.

Suto R, Abe Y, Lee YH, Ueyama Y, Yamazaki H, Kijima H, Hiraoka N, Fukuda H, Tamaoki N, Nakamura M.

Anticancer Res. 1997 May-Jun;17(3C):2273-7.

PMID:
9216701
40.

A xenograft line of human teratocarcinoma established by serial transplantation in severe combined immunodeficient (SCID) mice.

Abe Y, Oshika Y, Ohnishi Y, Suto R, Tokunaga T, Yamazaki H, Kijima H, Hiraoka N, Ueyama Y, Tamaoki N, Nakamura M.

APMIS. 1997 Apr;105(4):283-9.

PMID:
9164470
41.

Advantage of in vivo chemosensitivity assay to detect vincristine-resistance in a human epidermoid carcinoma xenograft.

Abe Y, Yamazaki H, Oshika Y, Suto R, Tsugu A, Ota E, Satoh H, Ohnishi Y, Yanagawa T, Ueyama Y, Tamaoki N, Nakamura M.

Anticancer Res. 1996 Mar-Apr;16(2):729-34.

PMID:
8687121
42.

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides.

Suto R, Srivastava PK.

Science. 1995 Sep 15;269(5230):1585-8.

PMID:
7545313
43.

Conversion of D-arabinose to D-erythroascorbic acid and oxalic acid in Sclerotinia sclerotiorum.

Loewus FA, Saito K, Suto RK, Maring E.

Biochem Biophys Res Commun. 1995 Jul 6;212(1):196-203.

PMID:
7612007
44.

Induction of murine gamma delta T cells cytotoxic for xenogeneic rat cells.

Okumura C, Suto R, Furukawa K, Ahmed SS, Furukawa K, Nakayama E, Fujii T, Shiku H.

J Immunol. 1995 Feb 1;154(3):1114-23.

PMID:
7822788
45.

Expression of the human multidrug resistance gene (MDR1) and prognostic correlation in human osteogenic sarcoma.

Imanishi T, Abe Y, Suto R, Higaki S, Ueyama Y, Nakamura M, Tamaoki N, Fukuda H, Imai N.

Tokai J Exp Clin Med. 1994 Sep;19(1-2):39-46.

PMID:
7660382
46.

Supplemental Content

Support Center